{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T13:46:20Z","timestamp":1784814380698,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Pathol"],"DOI":"10.1186\/s13000-025-01697-0","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:56:53Z","timestamp":1759233413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluating sensitivity of NGS-based mutation detection across diverse sample types in prostate cancer"],"prefix":"10.1186","volume":"20","author":[{"given":"Kui","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heyao","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongruo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gena","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanki","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"10","key":"1697_CR1","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer EM, Srinivas S, Adra N, An Y, Barocas D, Bitting R, et al. Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(10):1067\u201396.","journal-title":"J Natl Compr Canc Netw"},{"issue":"4","key":"1697_CR2","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1200\/JCO.2017.74.1173","volume":"36","author":"VN Giri","year":"2018","unstructured":"Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, et al. Role of genetic testing for inherited prostate cancer risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2018;36(4):414\u201324.","journal-title":"J Clin Oncol"},{"key":"1697_CR3","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1200\/EDBK_205441","volume":"38","author":"H Cheng","year":"2018","unstructured":"Cheng H, Powers J, Schaffer K, Sartor O. Practical methods for integrating genetic testing into clinical practice for advanced prostate cancer. Am Soc Clin Oncol Educ Book. 2018;38:372\u201381.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"1697_CR4","doi-asserted-by":"publisher","unstructured":"Wyatt AW, Annala M, Aggarwal R, Beja K, Feng F, Youngren J, et al. Concordance of circulating tumor DNA and matched metastatic tissue biopsy in prostate cancer. J Natl Cancer Inst. 2017. https:\/\/doi.org\/10.1093\/jnci\/djx118.","DOI":"10.1093\/jnci\/djx118"},{"key":"1697_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/PO.19.00176","volume":"3","author":"ST Hennigan","year":"2019","unstructured":"Hennigan ST, Trostel SY, Terrigino NT, Voznesensky OS, Schaefer RJ, Whitlock NC, et al. Low abundance of circulating tumor DNA in localized prostate cancer. JCO Precis Oncol. 2019;3:1.","journal-title":"JCO Precis Oncol"},{"issue":"4","key":"1697_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.eururo.2018.12.042","volume":"75","author":"G Vandekerkhove","year":"2019","unstructured":"Vandekerkhove G, Struss WJ, Annala M, Kallio HML, Khalaf D, Warner EW, et al. Circulating tumor DNA abundance and potential utility in de novo metastatic prostate cancer. Eur Urol. 2019;75(4):667\u201375.","journal-title":"Eur Urol"},{"issue":"4","key":"1697_CR7","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1158\/2159-8290.CD-17-0937","volume":"8","author":"M Annala","year":"2018","unstructured":"Annala M, Vandekerkhove G, Khalaf D, Taavitsainen S, Beja K, Warner EW, et al. Circulating tumor DNA genomics correlate with resistance to abiraterone and enzalutamide in prostate cancer. Cancer Discov. 2018;8(4):444\u201357.","journal-title":"Cancer Discov"},{"issue":"9","key":"1697_CR8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s41571-022-00660-y","volume":"19","author":"A Tivey","year":"2022","unstructured":"Tivey A, Church M, Rothwell D, Dive C, Cook N. Circulating tumour DNA - looking beyond the blood. Nat Rev Clin Oncol. 2022;19(9):600\u201312.","journal-title":"Nat Rev Clin Oncol"},{"issue":"9","key":"1697_CR9","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1111\/iju.13734","volume":"25","author":"K Fujita","year":"2018","unstructured":"Fujita K, Nonomura N. Urinary biomarkers of prostate cancer. Int J Urol. 2018;25(9):770\u20139.","journal-title":"Int J Urol"},{"issue":"16","key":"1697_CR10","doi-asserted-by":"publisher","first-page":"5015","DOI":"10.1158\/1078-0432.CCR-19-0585","volume":"25","author":"W Fang","year":"2019","unstructured":"Fang W, Ma Y, Yin JC, Hong S, Zhou H, Wang A, et al. Comprehensive genomic profiling identifies novel genetic predictors of response to anti-PD-(L)1 therapies in non-small cell lung cancer. Clin Cancer Res. 2019;25(16):5015\u201326.","journal-title":"Clin Cancer Res"},{"issue":"15","key":"1697_CR11","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320.","journal-title":"Bioinformatics"},{"issue":"5","key":"1697_CR12","first-page":"589","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics (Oxford, England). 2010;26(5):589\u201395.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"9","key":"1697_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The genome analysis toolkit: a mapreduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"},{"issue":"3","key":"1697_CR14","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568\u201376.","journal-title":"Genome Res"},{"key":"1697_CR15","doi-asserted-by":"crossref","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164-e.","DOI":"10.1093\/nar\/gkq603"},{"issue":"18","key":"1697_CR16","first-page":"i333","volume":"28","author":"T Rausch","year":"2012","unstructured":"Rausch T, Zichner T, Schlattl A, St\u00fctz AM, Benes V, Korbel JO. DELLY: structural variant discovery by integrated paired-end and split-read analysis. Bioinformatics (Oxford, England). 2012;28(18):i333\u20139.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"4","key":"1697_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1004873","volume":"12","author":"E Talevich","year":"2016","unstructured":"Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol. 2016;12(4): e1004873.","journal-title":"PLoS Comput Biol"},{"issue":"6","key":"1697_CR18","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.annonc.2021.03.196","volume":"32","author":"A Jayaram","year":"2021","unstructured":"Jayaram A, Wingate A, Wetterskog D, Wheeler G, Sternberg CN, Jones R, et al. Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multicenter international trial. Ann Oncol. 2021;32(6):726\u201335.","journal-title":"Ann Oncol"},{"issue":"2","key":"1697_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2024.108931","volume":"27","author":"B Yang","year":"2024","unstructured":"Yang B, Zhao T, Dong B, Chen W, Yang G, Xie J, et al. Circulating tumor DNA and tissue complementarily detect genomic alterations in metastatic hormone-sensitive prostate cancer. iScience. 2024;27(2): 108931.","journal-title":"iScience"},{"key":"1697_CR20","doi-asserted-by":"publisher","unstructured":"Rzhevskiy AS, Kapitannikova AY, Vasilescu SA, Karashaeva TA, Razavi Bazaz S, Taratkin MS, et al. Isolation of circulating tumor cells from seminal fluid of patients with prostate cancer using inertial microfluidics. Cancers (Basel). 2022. https:\/\/doi.org\/10.3390\/cancers14143364.","DOI":"10.3390\/cancers14143364"},{"key":"1697_CR21","doi-asserted-by":"publisher","unstructured":"Saitta C, De Simone I, Fasulo V, Corbetta M, Duga S, Chiereghin C, et al. Evaluation of semen self-sampling yield predictors and CTC isolation by multi-color flow cytometry for liquid biopsy of localized prostate cancer. Cancers (Basel). 2023. https:\/\/doi.org\/10.3390\/cancers15102666.","DOI":"10.3390\/cancers15102666"},{"issue":"4","key":"1697_CR22","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s12253-018-0416-6","volume":"24","author":"G Ponti","year":"2018","unstructured":"Ponti G, Maccaferri M, Mandrioli M, Manfredini M, Micali S, Cotugno M, et al. Seminal cell-free DNA assessment as a novel prostate cancer biomarker. Pathol Oncol Res. 2018;24(4):941\u20135.","journal-title":"Pathol Oncol Res"},{"key":"1697_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cca.2019.07.011","volume":"497","author":"G Ponti","year":"2019","unstructured":"Ponti G, Maccaferri M, Manfredini M, Micali S, Torricelli F, Milandri R, et al. Quick assessment of cell-free DNA in seminal fluid and fragment size for early non-invasive prostate cancer diagnosis. Clin Chim Acta. 2019;497:76\u201380.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"1697_CR24","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/ijc.34434","volume":"152","author":"S Jordaens","year":"2023","unstructured":"Jordaens S, Zwaenepoel K, Tjalma W, Deben C, Beyers K, Vankerckhoven V, et al. Urine biomarkers in cancer detection: a systematic review of preanalytical parameters and applied methods. Int J Cancer. 2023;152(10):2186\u2013205.","journal-title":"Int J Cancer"},{"key":"1697_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.957404","volume":"12","author":"J Zhou","year":"2022","unstructured":"Zhou J, Lai Y, Peng S, Tang C, Chen Y, Li L, et al. Comprehensive analysis of TP53 and SPOP mutations and their impact on survival in metastatic prostate cancer. Front Oncol. 2022;12: 957404.","journal-title":"Front Oncol"},{"issue":"1","key":"1697_CR26","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s13238-020-00786-8","volume":"12","author":"M Teng","year":"2021","unstructured":"Teng M, Zhou S, Cai C, Lupien M, He HH. Pioneer of prostate cancer: past, present and the future of FOXA1. Protein Cell. 2021;12(1):29\u201338.","journal-title":"Protein Cell"},{"issue":"8","key":"1697_CR27","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00018-022-04456-2","volume":"79","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Hu X, Yu H, Liu X, Sun H, Shao C. Alternations of gene expression in PI3K and AR pathways and DNA methylation features contribute to metastasis of prostate cancer. Cell Mol Life Sci. 2022;79(8):436.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"1697_CR28","doi-asserted-by":"publisher","first-page":"16597","DOI":"10.1038\/s41598-023-43767-7","volume":"13","author":"IA Tsydenova","year":"2023","unstructured":"Tsydenova IA, Ibragimova MK, Tsyganov MM, Litviakov NV. Human papillomavirus and prostate cancer: systematic review and meta-analysis. Sci Rep. 2023;13(1):16597.","journal-title":"Sci Rep"},{"key":"1697_CR29","doi-asserted-by":"publisher","DOI":"10.1530\/ETJ-22-0228","author":"S Torabinejad","year":"2023","unstructured":"Torabinejad S, Miro C, Barone B, Imbimbo C, Crocetto F, Dentice M. The androgen-thyroid hormone crosstalk in prostate cancer and the clinical implications. Eur Thyroid J. 2023. https:\/\/doi.org\/10.1530\/ETJ-22-0228.","journal-title":"Eur Thyroid J"},{"issue":"3","key":"1697_CR30","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.3892\/ijo.2012.1509","volume":"41","author":"D Carri\u00f3n-Salip","year":"2012","unstructured":"Carri\u00f3n-Salip D, Panosa C, Menendez JA, Puig T, Oliveras G, Pandiella A, et al. Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands. Int J Oncol. 2012;41(3):1128\u201338.","journal-title":"Int J Oncol"},{"issue":"3","key":"1697_CR31","doi-asserted-by":"publisher","first-page":"287","DOI":"10.4103\/aja202259","volume":"25","author":"HY Dong","year":"2023","unstructured":"Dong HY, Ding L, Zhou TR, Yan T, Li J, Liang C. FOXA1 in prostate cancer. Asian J Androl. 2023;25(3):287\u201395.","journal-title":"Asian J Androl"},{"issue":"18","key":"1697_CR32","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.3390\/cancers14184381","volume":"14","author":"H Cai","year":"2022","unstructured":"Cai H, Agersnap SN, Sj\u00f8gren A, Simonsen MK, Blaavand MS, Jensen UV, et al. In vivo application of CRISPR\/Cas9 revealed implication of Foxa1 and Foxp1 in prostate cancer proliferation and epithelial plasticity. Cancers. 2022;14(18):4381.","journal-title":"Cancers"},{"key":"1697_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-024-00805-3","author":"ZB Zengin","year":"2024","unstructured":"Zengin ZB, Henderson NC, Park JJ, Ali A, Nguyen C, Hwang C, et al. Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration. Prostate Cancer Prostatic Dis. 2024. https:\/\/doi.org\/10.1038\/s41391-024-00805-3.","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"1","key":"1697_CR34","doi-asserted-by":"publisher","first-page":"5070","DOI":"10.1038\/s41467-020-18843-5","volume":"11","author":"DJ Woodcock","year":"2020","unstructured":"Woodcock DJ, Riabchenko E, Taavitsainen S, Kankainen M, Gundem G, Brewer DS, et al. Prostate cancer evolution from multilineage primary to single lineage metastases with implications for liquid biopsy. Nat Commun. 2020;11(1):5070.","journal-title":"Nat Commun"},{"issue":"10","key":"1697_CR35","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.ccell.2022.09.002","volume":"40","author":"DY Takeda","year":"2022","unstructured":"Takeda DY, Sowalsky AG. Unpacking circulating tumor DNA lends insight into prostate cancer biology and the clonal dynamics of metastasis. Cancer Cell. 2022;40(10):1086\u20138.","journal-title":"Cancer Cell"},{"issue":"5","key":"1697_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/aja.2010.89","volume":"12","author":"S Koochekpour","year":"2010","unstructured":"Koochekpour S. Androgen receptor signaling and mutations in prostate cancer. Asian J Androl. 2010;12(5):639\u201357.","journal-title":"Asian J Androl"},{"issue":"1\u20132","key":"1697_CR37","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1159\/000477852","volume":"85","author":"Y Tolkach","year":"2018","unstructured":"Tolkach Y, Kristiansen G. The heterogeneity of prostate cancer: a practical approach. Pathobiology. 2018;85(1\u20132):108\u201316.","journal-title":"Pathobiology"}],"container-title":["Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01697-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13000-025-01697-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13000-025-01697-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:04:00Z","timestamp":1759277040000},"score":1,"resource":{"primary":{"URL":"https:\/\/diagnosticpathology.biomedcentral.com\/articles\/10.1186\/s13000-025-01697-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1697"],"URL":"https:\/\/doi.org\/10.1186\/s13000-025-01697-0","relation":{},"ISSN":["1746-1596"],"issn-type":[{"value":"1746-1596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"28 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethic approval is waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YM, EP and JY are employees of Nanjing Geneseeq Technology Inc., Nanjing, China, but declare no non-financial competing interests. Other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"108"}}